0 items USD 0.00Search
Your search for "globaldata relapsed chronic lymphocytic leukemia cll global clinical trials review h1 2018" gave back 688391 results.
The global Bendamustine Injection market is projected to reach US$ 965.1 million in 2029, increasing from US$ 792.3 million in 2022, with the CAGR of...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Ibrutinib market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Chronic Myeloid Leukemia (CML) Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
It is a highly potent opioid analgesic indicated for treatment of severe pain The global Oxymorphone Hydrochloride market is projected to reach US$...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Bruton's Tyrosine Kinase Inhibitors (BTKi), Bruton's TKI or BTKI, Ibrutinib, has shown great promise for B cell cancers with the...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global CD20 Target Drug market size was valued at US$ million in 2022. With growing demand in downstream market, the CD20 Target Drug is forecast...
Catalog:
LPI
November 2023
Price: USD 3,660.00
Fludarabine Phosphate (CAS 75607-67-9), C10H13FN5O7P, the formula weight is 365.21, and its white powder. The global Fludarabine Phosphate market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Recombinant human interferon α1b for injection is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Besponsa...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Bendamustine hydrochloride injection is a cytotoxic drug used to treat chronic lymphoblastic leukemia and non Hodgkin's lymphoma. The global...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Chronic myeloid leukaemia (CML) is a type cancer that affects the blood and bone marrow. The global Chronic Myeloid Leukemia (CML) Treatment market...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
CD20 is a cell surface antigen that usually appears on the surface of B lymphocytes. CD20-targeted drugs are a class of drugs used to treat specific...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
